期刊文献+

三种不同冲洗液在ICU动脉置管患者中的应用及对凝血功能的影响 被引量:6

Effects of different heparin-containing flushing solutions on the coagulation function of patients with arterial catheters in ICU
下载PDF
导出
摘要 目的:探讨ICU危重症患者在低分子肝素抗凝治疗的同时将生理盐水冲洗液替代肝素冲洗液使用的可行性。方法将120例行桡动脉穿刺监测血压的患者随机分为3组,A组肝素冲洗液浓度为2.5 U/ml,B组肝素冲洗液浓度为1 U/ml,C组为生理盐水。置管期间每6 h进行一次导管通畅性监测试验。记录动脉堵管发生率、平均动脉置管时间、动脉穿刺点渗血发生率。分别于入院时、置管1天、置管3天、置管5天、置管7天、拔管时、拔管后3天、拔管后7天抽取动脉血4 ml,监测凝血功能。结果实验过程中,3组导管保持通畅。3组冲洗液在堵管发生率及置管天数上无显著差异(P>0.05)。 A组患者穿刺点渗血明显高于其他两组,差异具有统计学意义(P<0.05)。3组患者的凝血检测指标无显著性差异(P>0.05)。结论生理盐水冲洗液可有效维护动脉导管的通畅性,并降低不良反应,值得临床推广应用。 Objective To investigate the application of saline flushing solution as a substitute of heparin -contai-ning flushing solution in critically ill patients in ICU during their low -molecular -weight heparin ( LMWH) therapy. Methods A total of 120 patients who underwent invasive arterial pressure monitoring were included into the current study .These patients were randomly divided into three groups , according to the flushing solutions used .Catheter patency was monitored every 6 hours.Then, arterial blood samples was drawn on admission , Days 1, 3, 5 and 7 of catheter placement, immediately after extubation , and 3 and 7 days after extubation to assess coagulation function .Results Catheter patency was maintained during the experiments .No statistical difference was found in the incidence of arterial blockage and the time of catheter placement different among these groups (P〉0.05).However, capillary hemorrhage was more frequently observed at the arterial puncture sites of Group A than those in other group (P〈0.05).There were no significant differences in coagulation indexes in all patients (P〉0.05).Conclusion Saline flushing solution can ef-fectively guarantee catheter patency and reduce adverse reactions , which is worth of clinical practice .
出处 《徐州医学院学报》 CAS 2016年第1期43-45,共3页 Acta Academiae Medicinae Xuzhou
基金 南京市医学发展课题(ykk12132)
关键词 有创动脉测压 肝素冲洗液 生理盐水冲洗液 导管通畅性 凝血功能 invasive arterial pressure monitoring heparin-containing flushing solution saline flushing solution catheter patency coagulation function
  • 相关文献

参考文献9

二级参考文献22

  • 1张德锦,罗秋菊,郭鹏.130例慢性肺心病血液流变学观察[J].心血管康复医学杂志,1999,8(2):59-60. 被引量:6
  • 2黄林锋,董仁寿.低分子肝素干预下肺心病凝血功能与肺功能的相关性[J].中国血液流变学杂志,2005,15(1):83-85. 被引量:10
  • 3沈富女,魏惠燕,金向红.从桡动脉及中心静脉置管采血检测活化部分凝血活酶时间的可行性研究[J].中华护理杂志,2006,41(6):544-545. 被引量:14
  • 4Warkentin TE,Greinacher A.Heparin-induced thrombocytopenia:recognition,treatment and prevention:the Seventh ACCP conference on antithrombotic and thrombolytic therapy[J].Chest,2004,126:311-337.
  • 5Gustavo BF,Oliveria,Eric M,et al.Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy[J].Arch Intern Meal,2008,168(1):94-102.
  • 6Warkentin T.Heparin-induced thrombocytopenia:pathogenesis and management[J].Br J Haematol,2003,121:535-555.
  • 7Craig S,Kitchens.Thrombocytopenia and thrombosis in disseminated intravoscular coagulation (DIC)[J].American Society of Hematolagy,2009,240-246.
  • 8Wendy Lim.Antiphospholipid antibody syndrome[J].American Society of Hematology,2009,233-239.
  • 9Kannan,Meganathana,Ahmad,et al.Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian Indians:relevance to inflammatory markers[J].Blood coagulation &fihrinolysis,2008,19(6):471-475.
  • 10Warkentin TE,Kelton JG.Temporal aspects of heparin-induced thrombocytopenia[J].N Engl J Med,2001,344:1286-1292.

共引文献49

同被引文献54

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部